For the year ending 2025-12-31, VIR has $1,002,823K in assets. $237,547K in debts. $232,185K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 232,185 | |||
| Short-term investments | 228,753 | |||
| Restricted cash and cash equivalents, current | 1,922 | |||
| Equity investments | 6,077 | |||
| Prepaid expenses and other current assets | 45,143 | |||
| Total current assets | 514,080 | |||
| Intangible assets, net | 7,850 | |||
| Goodwill | 16,937 | |||
| Property and equipment, net | 55,620 | |||
| Operating right-of-use assets | 62,099 | |||
| Restricted cash and cash equivalents, noncurrent | 6,963 | |||
| Long-term investments | 314,575 | |||
| Other assets | 24,699 | |||
| Total assets | 1,002,823 | |||
| Accounts payable | 9,803 | |||
| Accrued and other liabilities | 83,012 | |||
| Contingent consideration obligation, current | 0 | |||
| Total current liabilities | 92,815 | |||
| Operating lease liabilities, noncurrent | 89,054 | |||
| Contingent consideration obligation, noncurrent | 34,100 | |||
| Other long-term liabilities | 21,578 | |||
| Total liabilities | 237,547 | |||
| Common stock, 0.0001 par value 300,000,000 shares authorized as of december31, 2025 and 2024, respectively 139,474,954 and 136,959,446 shares issued and outstanding as of december31, 2025 and 2024, respectively | 14 | |||
| Additional paid-in capital | 1,965,090 | |||
| Accumulated other comprehensive loss | -2,057 | |||
| Accumulated deficit | -1,197,771 | |||
| Total stockholders equity | 765,276 | |||
| Total liabilities and stockholders equity | 1,002,823 | |||
Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR)